News | April 09, 2014

New Ultrasound Method Predicts Blood Clots in the Heart, Brain

Cardiac Ultrasound Blood Clots Heart Brain ACC.14

April 9, 2014 — A study with a new ultrasonic scanning technique shows that scanning of the carotid arteries can reveal who is at high risk of being hit by a blood clot. Scanning examines the patient for atherosclerosis, which causes the vast majority of blood clots in the heart, brain or elsewhere in the body

The study "Detection and Impact of Subclinical Coronary and Carotid Atherosclerosis on Cardiovascular Risk Prediction and Reclassification in Asymptomatic U.S. Adults: Insights from the High Risk Plaque Bioimage Study," was presented at the American College of Cardiology (ACC) 2014. Nearly 6,000 apparently healthy Americans participated in the study from 2009 to 2010. The patients received an ultrasound scan of the carotid arteries and computed tomography (CT) scans of the heart. They were then followed to ascertain who got blood clots and other cardiovascular diseases.

Henrik Sillesen, M.D., department of vascular surgery, University Hospital Copenhagen, Denmark, was responsible for conducting and analyzing all cardiac ultrasound scans. He said, "By scanning both carotid arteries and calculating a measure of how much atherosclerosis was present, we could show that those who had much atherosclerosis were three times as likely to develop coronary heart disease in the form of thrombosis, need for heart surgery, etc., as those who had veins without evidence of atherosclerosis. Even those with only moderate amounts of atherosclerosis had more than twice as likely as those with normal veins. "

Ultrasound proved to be just as good as cardiac CT scan, which hitherto has been considered the best method. Since ultrasound equipment is smaller, less expensive, mobile and does not use X-rays, the study suggests this method may be better than CT for the study of healthy people who want to know if they are at risk.

For more information: content.onlinejacc.org/article.aspx?articleid=1856105

 

Related Content

New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
Overlay Init